Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$0.60 USD
0.00 (0.48%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.60 0.00 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Relmada Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RLMD 0.60 0.00(0.48%)
Will RLMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RLMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RLMD
Relmada Therapeutics (RLMD) Loses -43.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
RLMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RLMD
Relmada Therapeutics Inc (RLMD) Q2 2025 Earnings Call Highlights: Strategic Advancements and ...
Q2 2025 Relmada Therapeutics Inc Earnings Call Transcript
Relmada Therapeutics GAAP EPS of -$0.30
Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, ...
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket